Related Experiment Video
Updated: Jan 27, 2026
How to Obtain Reliable Visual Event-related Potentials in Newborns
Published on: October 24, 2019
Guidelines for vitamin K prophylaxis in newborns
1Canadian Paediatric Society, Fetus and Newborn Committee, Ottawa, Ontario.
Insights
A single intramuscular vitamin K injection at birth is the most effective way to prevent vitamin K deficiency bleeding (VKDB) in newborns. Oral vitamin K is less effective and should only be used if parents decline the injection.
Area of Science:
- Neonatal Medicine
- Pediatrics
- Pharmacology
Background:
- Newborns face risks of vitamin K deficiency bleeding (VKDB) due to low prenatal stores and vitamin K levels in breast milk.
- VKDB can lead to serious health complications if not prevented.
Purpose of the Study:
- To review the evidence on vitamin K administration methods for preventing VKDB in newborns.
- To provide recommendations for routine vitamin K prophylaxis in neonates.
Main Methods:
- Systematic review of existing scientific evidence on vitamin K administration routes (IM, PO, IV).
- Analysis of comparative effectiveness of different vitamin K prophylaxis strategies.
Main Results:
- A single intramuscular (IM) dose of vitamin K at birth is highly effective in preventing VKDB.
- Oral (PO) vitamin K, whether single or repeated doses, is less effective than IM administration.
- Evidence is insufficient to support routine intravenous vitamin K for preterm infants in intensive care.
Conclusions:
- Routine IM administration of a single vitamin K dose (0.5-1.0 mg) is recommended for all newborns.
- PO vitamin K should be reserved for cases where parents refuse IM administration, with clear counseling on increased VKDB risk.
- Further research is needed for optimal vitamin K strategies in specific neonatal populations.
Abstract:
Newborns are at risk for vitamin K deficiency bleeding (VKDB) caused by inadequate prenatal storage and deficiency of vitamin K in breast milk. Systematic review of evidence to date suggests that a single intramuscular (IM) injection of vitamin K at birth effectively prevents VKDB. Current scientific data suggest that single or repeated doses of oral (PO) vitamin K are less effective than IM vitamin K in preventing VKDB. The Canadian Paediatric Society and the College of Family Physicians of Canada recommend routine IM administration of a single dose vitamin K at 0.5 mg to 1.0 mg to all newborns. Administering PO vitamin K (2.0 mg at birth, repeated at 2 to 4 and 6 to 8 weeks of age), should be confined to newborns whose parents decline IM vitamin K. Health care providers should clarify with parents that newborns are at increased risk of VKDB if such a regimen is chosen. Current evidence is insufficient to recommend routine intravenous vitamin K administration to preterm infants undergoing intensive care.
Related Concept Videos
01:30Vitamins
01:26Guidelines for Nursing Documentation II
Timely documentation is crucial to ensure continuity of care for patients. Any delays in recording or reporting medical information can result in medical errors and even adverse patient outcomes. From medication administration to diagnostic test results, every detail must be accurately and promptly documented to provide the best possible care for patients.
01:06Legal Guidelines for Documentation
01:23Guidelines for Sketching a Curve
01:11Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
01:30Guidelines for Nursing Documentation I
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.